Advertisement

Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain

Published:November 21, 2018DOI:https://doi.org/10.1016/j.jpain.2018.11.001

      Abstract

      Paclitaxel-induced peripheral neuropathy (PIPN) and associated neuropathic pain are the most common and serious adverse effects experienced by cancer patients receiving paclitaxel treatment. These effects adversely impact daily activities and consequently the quality of life, sometimes forcing the suspension of treatment and negatively influencing survival. Patients are usually at high risk of developing PIPN if paclitaxel induces acute pain, which strongly suggests that an acute increase in the excitability of nociceptors underlies the chronic alterations of PIPN. KCNQ/Kv7 channels are widely expressed in the primary sensory neurons to modulate their excitability. In the present study, we show that targeting KCNQ/Kv7 channels at an early stage is an effective strategy to attenuate the development of PIPN. We found that paclitaxel did not decrease the expression level of KCNQ/Kv7 channels in the primary sensory neurons as detected by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and Western blotting. However, retigabine, which is a specific KCNQ/Kv7 channel opener, attenuated significantly the development of PIPN, as shown by both morphologic and behavioral evidence. We also observed that retigabine had no obvious effect on the chemosensitivity of breast cancer cells to paclitaxel. Although retigabine has been approved by the FDA as an anticonvulsant, our study suggests that this drug can be repurposed to attenuate the development of PIPN.

      Perspective

      Paclitaxel-induced peripheral neuropathy and associated neuropathic pain are severe and resistant to intervention. The results of our study demonstrated that retigabine (a clinically available medicine) can be used to attenuate the development of paclitaxel-induced peripheral neuropathy.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abram SE
        • Yi J
        • Fuchs A
        • Hogan QH
        Permeability of injured and intact peripheral nerves and dorsal root ganglia.
        Anesthesiology. 2006; 105: 146-153
        • Aizawa N
        • Wakamatsu D
        • Kida J
        • Otsuki T
        • Saito Y
        • Matsuya H
        • Homma Y
        • Igawa Y
        Inhibitory effects of retigabine, a Kv7 channel activator, on mechanosensitive primary bladder afferent activities and nociceptive behaviors in rats.
        Neurourol Urodyn. 2017; 36: 280-285
        • Armstrong CM
        • Cota G
        Calcium block of Na+ channels and its effect on closing rate.
        Proc Natl Acad Sci U S A. 1999; 96: 4154-4157
      1. Barriere DA, Rieusset J, Chanteranne D, Busserolles J, Chauvin MA, Chapuis L, Salles J, Dubray C, Morio B: Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization. Pain 153:553-561, 2012

        • Blackburn-Munro G
        • Jensen BS
        The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain.
        Eur J Pharmacol. 2003; 460: 109-116
        • Boscia F
        • Annunziato L
        • Taglialatela M
        Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures.
        Neuropharmacology. 2006; 51: 283-294
        • Boyette-Davis J
        • Xin W
        • Zhang H
        • Dougherty PM
        Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline.
        Pain. 2011; 152: 308-313
        • Burgos E
        • Gomez-Nicola D
        • Pascual D
        • Martin MI
        • Nieto-Sampedro M
        • Goicoechea C
        Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats: Possible involvement of spinal glial cells.
        Eur J Pharmacol. 2012; 682: 62-72
        • Cavaletti G
        • Cavalletti E
        • Oggioni N
        • Sottani C
        • Minoia C
        • D'Incalci M
        • Zucchetti M
        • Marmiroli P
        • Tredici G
        Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration.
        Neurotoxicology. 2000; 21: 389-393
        • Chadha PS
        • Zunke F
        • Zhu HL
        • Davis AJ
        • Jepps TA
        • Olesen SP
        • Cole WC
        • Moffatt JD
        • Greenwood IA
        Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired beta-adrenoceptor-mediated relaxation of renal arteries in hypertension.
        Hypertension. 2012; 59: 877-884
        • Chaplan SR
        • Bach FW
        • Pogrel JW
        • Chung JM
        • Yaksh TL
        Quantitative assessment of tactile allodynia in the rat paw.
        J Neurosci Methods. 1994; 53: 55-63
        • Crown J
        • O'Leary M
        • Ooi WS
        Docetaxel and paclitaxel in the treatment of breast cancer: A review of clinical experience.
        Oncologist. 2004; 9: 24-32
        • Devor M
        Unexplained peculiarities of the dorsal root ganglion.
        Pain. 1999; : S27-S35
        • Drug Enforcement Administration DoJ
        Schedules of controlled substances: Placement of ezogabine into Schedule V: Final rule.
        Fed Regist. 2011; 76: 77895-77899
        • Du X
        • Hao H
        • Gigout S
        • Huang D
        • Yang Y
        • Li L
        • Wang C
        • Sundt D
        • Jaffe DB
        • Zhang H
        • Gamper N
        Control of somatic membrane potential in nociceptive neurons and its implications for peripheral nociceptive transmission.
        Pain. 2014; 155: 2306-2322
        • Duggett NA
        • Griffiths LA
        • Flatters SJL
        Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons.
        Pain. 2017; 158: 1499-1508
        • Erecinska M
        • Nelson D
        • Yudkoff M
        • Silver IA
        Energetics of the nerve terminal in relation to central nervous system function.
        Biochem Soc Trans. 1994; 22: 959-965
        • Erecinska M
        • Silver IA
        Ions and energy in mammalian brain.
        Prog Neurobiol. 1994; 43: 37-71
        • Farquhar-Smith P
        Chemotherapy-induced neuropathic pain.
        Curr Opin Support Palliat Care. 2011; 5: 1-7
        • Fidanboylu M
        • Griffiths LA
        • Flatters SJ
        Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy.
        PloS One. 2011; 6: e25212
        • Flatters SJ
        • Bennett GJ
        Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction.
        Pain. 2006; 122: 245-257
        • Flatters SJ
        • Xiao WH
        • Bennett GJ
        Acetyl-l-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.
        Neurosci Lett. 2006; 397: 219-223
        • Gamelin L
        • Boisdron-Celle M
        • Delva R
        • Guerin-Meyer V
        • Ifrah N
        • Morel A
        • Gamelin E
        Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: A retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer.
        Clin Cancer Res. 2004; 10: 4055-4061
        • Gamelin L
        • Boisdron-Celle M
        • Morel A
        • Poirier AL
        • Berger V
        • Gamelin E
        • Tournigand C
        • de Gramont A
        Oxaliplatin-related neurotoxicity: Interest of calcium-magnesium infusion and no impact on its efficacy.
        J Clin Oncol. 2008; 26 (author reply 1189-1190): 1188-1189
        • Hara T
        • Chiba T
        • Abe K
        • Makabe A
        • Ikeno S
        • Kawakami K
        • Utsunomiya I
        • Hama T
        • Taguchi K
        Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion.
        Pain. 2013; 154: 882-889
        • Hermann R
        • Ferron GM
        • Erb K
        • Knebel N
        • Ruus P
        • Paul J
        • Richards L
        • Cnota HP
        • Troy S
        Effects of age and sex on the disposition of retigabine.
        Clin Pharmacol Ther. 2003; 73: 61-70
        • Hershman DL
        • Lacchetti C
        • Dworkin RH
        • Lavoie Smith EM
        • Bleeker J
        • Cavaletti G
        • Chauhan C
        • Gavin P
        • Lavino A
        • Lustberg MB
        • Paice J
        • Schneider B
        • Smith ML
        • Smith T
        • Terstriep S
        • Wagner-Johnston N
        • Bak K
        • Loprinzi CL
        • American Society of Clinical O
        Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
        J Clin Oncol. 2014; 32: 1941-1967
        • Hershman DL
        • Unger JM
        • Crew KD
        • Minasian LM
        • Awad D
        • Moinpour CM
        • Hansen L
        • Lew DL
        • Greenlee H
        • Fehrenbacher L
        • Wade 3rd, JL
        • Wong SF
        • Hortobagyi GN
        • Meyskens FL
        • Albain KS
        Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.
        J Clin Oncol. 2013; 31: 2627-2633
        • Hirakawa H
        • Okajima S
        • Nagaoka T
        • Kubo T
        • Takamatsu T
        • Oyamada M
        Regional differences in blood-nerve barrier function and tight-junction protein expression within the rat dorsal root ganglion.
        Neuroreport. 2004; 15: 405-408
        • Hochster HS
        • Grothey A
        • Childs BH
        Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity.
        J Clin Oncol. 2007; 25: 4028-4029
        • Hwang BY
        • Kim ES
        • Kim CH
        • Kwon JY
        • Kim HK
        Gender differences in paclitaxel-induced neuropathic pain behavior and analgesic response in rats.
        Korean J Anesthesiol. 2012; 62: 66-72
        • Jentsch TJ
        Neuronal KCNQ potassium channels: Physiology and role in disease.
        Nat Rev Neurosci. 2000; 1: 21-30
        • Jimenez-Andrade JM
        • Herrera MB
        • Ghilardi JR
        • Vardanyan M
        • Melemedjian OK
        • Mantyh PW
        Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: Implications for chemical-induced peripheral sensory neuropathies.
        Mol Pain. 2008; 4: 10
        • Kalliomaki M
        • Kieseritzky JV
        • Schmidt R
        • Hagglof B
        • Karlsten R
        • Sjogren N
        • Albrecht P
        • Gee L
        • Rice F
        • Wiig M
        • Schmelz M
        • Gordh T
        Structural and functional differences between neuropathy with and without pain?.
        Exp Neurol. 2011; 231: 199-206
        • Kottschade LA
        • Sloan JA
        • Mazurczak MA
        • Johnson DB
        • Murphy BP
        • Rowland KM
        • Smith DA
        • Berg AR
        • Stella PJ
        • Loprinzi CL
        The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: Results of a randomized phase III clinical trial.
        Support Care Cancer. 2011; 19: 1769-1777
        • Kurniali PC
        • Luo LG
        • Weitberg AB
        Role of calcium/ magnesium infusion in oxaliplatin-based chemotherapy for colorectal cancer patients.
        Oncology (Williston Park). 2010; 24: 289-292
        • Leal AD
        • Qin R
        • Atherton PJ
        • Haluska P
        • Behrens RJ
        • Tiber CH
        • Watanaboonyakhet P
        • Weiss M
        • Adams PT
        • Dockter TJ
        • Loprinzi CL
        • Alliance for Clinical Trials in O
        North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study.
        Cancer. 2014; 120: 1890-1897
        • Li Y
        • North RY
        • Rhines LD
        • Tatsui CE
        • Rao G
        • Edwards DD
        • Cassidy RM
        • Harrison DS
        • Johansson CA
        • Zhang H
        • Dougherty PM
        DRG voltage-gated sodium channel 1.7 Is upregulated in paclitaxel-induced neuropathy in rats and in humans with neuropathic pain.
        J Neurosci. 2018; 38: 1124-1136
        • Li Y
        • Tatsui CE
        • Rhines LD
        • North RY
        • Harrison DS
        • Cassidy RM
        • Johansson CA
        • Kosturakis AK
        • Edwards DD
        • Zhang H
        • Dougherty PM
        Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy.
        Pain. 2017; 158: 417-429
        • Li Y
        • Zhang H
        • Zhang H
        • Kosturakis AK
        • Jawad AB
        • Dougherty PM
        Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.
        J Pain. 2014; 15: 712-725
        • Linley JE
        • Rose K
        • Patil M
        • Robertson B
        • Akopian AN
        • Gamper N
        Inhibition of M current in sensory neurons by exogenous proteases: A signaling pathway mediating inflammatory nociception.
        J Neurosci. 2008; 28: 11240-11249
        • Loprinzi CL
        • Reeves BN
        • Dakhil SR
        • Sloan JA
        • Wolf SL
        • Burger KN
        • Kamal A
        • Le-Lindqwister NA
        • Soori GS
        • Jaslowski AJ
        • Novotny PJ
        • Lachance DH
        Natural history of paclitaxel-associated acute pain syndrome: Prospective cohort study NCCTG N08C1.
        J Clin Oncol. 2011; 29: 1472-1478
        • Main MJ
        • Cryan JE
        • Dupere JR
        • Cox B
        • Clare JJ
        • Burbidge SA
        Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
        Mol Pharmacol. 2000; 58: 253-262
        • Milligan ED
        • Watkins LR
        Pathological and protective roles of glia in chronic pain.
        Nat Rev Neurosci. 2009; 10: 23-36
        • Mosmann T
        Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays.
        J Immunol Methods. 1983; 65: 55-63
        • Nishio K
        • Arioka H
        • Ishida T
        • Fukumoto H
        • Kurokawa H
        • Sata M
        • Ohata M
        • Saijo N
        Enhanced interaction between tubulin and microtubule-associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxel.
        Int J Cancer. 1995; 63: 688-693
        • Nodera H
        • Spieker A
        • Sung M
        • Rutkove S
        Neuroprotective effects of Kv7 channel agonist, retigabine, for cisplatin-induced peripheral neuropathy.
        Neurosci Lett. 2011; 505: 223-227
        • Nolano M
        • Simone DA
        • Wendelschafer-Crabb G
        • Johnson T
        • Hazen E
        • Kennedy WR
        Topical capsaicin in humans: Parallel loss of epidermal nerve fibers and pain sensation.
        Pain. 1999; 81: 135-145
        • Passmore GM
        • Selyanko AA
        • Mistry M
        • Al-Qatari M
        • Marsh SJ
        • Matthews EA
        • Dickenson AH
        • Brown TA
        • Burbidge SA
        • Main M
        • Brown DA
        KCNQ/M currents in sensory neurons: Significance for pain therapy.
        J Neurosci. 2003; 23: 7227-7236
        • Peters CM
        • Jimenez-Andrade JM
        • Jonas BM
        • Sevcik MA
        • Koewler NJ
        • Ghilardi JR
        • Wong GY
        • Mantyh PW
        Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells.
        Exp Neurol. 2007; 203: 42-54
        • Pevida M
        • Lastra A
        • Hidalgo A
        • Baamonde A
        • Menendez L
        Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia.
        Brain Res Bull. 2013; 95: 21-27
        • Piller N
        • Decosterd I
        • Suter MR
        Reverse transcription quantitative real-time polymerase chain reaction reference genes in the spared nerve injury model of neuropathic pain: validation and literature search.
        BMC Res Notes. 2013; 6: 266
        • Reeves BN
        • Dakhil SR
        • Sloan JA
        • Wolf SL
        • Burger KN
        • Kamal A
        • Le-Lindqwister NA
        • Soori GS
        • Jaslowski AJ
        • Kelaghan J
        • Novotny PJ
        • Lachance DH
        • Loprinzi CL
        Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.
        Cancer. 2012; 118: 5171-5178
        • Rekling JC
        Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation.
        Neurosci Lett. 2003; 335: 167-170
        • Rose K
        • Ooi L
        • Dalle C
        • Robertson B
        • Wood IC
        • Gamper N
        Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury.
        Pain. 2011; 152: 742-754
        • Rossato MF
        • Rigo FK
        • Oliveira SM
        • Guerra GP
        • Silva CR
        • Cunha TM
        • Gomez MV
        • Ferreira J
        • Trevisan G
        Participation of transient receptor potential vanilloid 1 in paclitaxel-induced acute visceral and peripheral nociception in rodents.
        Eur J Pharmacol. 2018; 828: 42-51
        • Roza C
        • Lopez-Garcia JA
        Retigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres.
        Pain. 2008; 138: 537-545
        • Seretny M
        • Currie GL
        • Sena ES
        • Ramnarine S
        • Grant R
        • MacLeod MR
        • Colvin LA
        • Fallon M
        Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.
        Pain. 2014; 155: 2461-2470
        • Shemesh OA
        • Spira ME
        Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: Implications for the pathogenesis of paclitaxel-induced polyneuropathy.
        Acta Neuropathologica. 2010; 119: 235-248
        • Wang HS
        • Pan Z
        • Shi W
        • Brown BS
        • Wymore RS
        • Cohen IS
        • Dixon JE
        • McKinnon D
        KCNQ2 and KCNQ3 potassium channel subunits: Molecular correlates of the M-channel.
        Science. 1998; 282: 1890-1893
        • Wu Z
        • Li L
        • Xie F
        • Du J
        • Zuo Y
        • Frost JA
        • Carlton SM
        • Walters ET
        • Yang Q
        Activation of KCNQ channels suppresses spontaneous activity in dorsal root ganglion neurons and reduces chronic pain after spinal cord injury.
        J Neurotrauma. 2017; 34: 1260-1270
        • Xiao WH
        • Bennett GJ
        Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.
        Pain. 2012; 153: 704-709
        • Xiao WH
        • Zheng H
        • Zheng FY
        • Nuydens R
        • Meert TF
        • Bennett GJ
        Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.
        Neuroscience. 2011; 199: 461-469
        • Xie W
        • Strong JA
        • Zhang JM
        Early blockade of injured primary sensory afferents reduces glial cell activation in two rat neuropathic pain models.
        Neuroscience. 2009; 160: 847-857
        • Xu W
        • Wu Y
        • Bi Y
        • Tan L
        • Gan Y
        • Wang K
        Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats.
        Mol Pain. 2010; 6: 49
        • Yang Q
        • Wu Z
        • Hadden JK
        • Odem MA
        • Zuo Y
        • Crook RJ
        • Frost JA
        • Walters ET
        Persistent pain after spinal cord injury is maintained by primary afferent activity.
        J Neurosci. 2014; 34: 10765-10769
        • Zhang H
        • Dougherty PM
        Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy.
        Anesthesiology. 2014; 120: 1463-1475
        • Zhang H
        • Li Y
        • de Carvalho-Barbosa M
        • Kavelaars A
        • Heijnen CJ
        • Albrecht PJ
        • Dougherty PM
        Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy-induced peripheral neuropathy.
        J Pain. 2016; 17: 775-786
        • Zhang H
        • Yoon SY
        • Dougherty PM
        Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of paclitaxel-induced painful neuropathy.
        J Pain. 2012; 13: 293-303
        • Zheng FY
        • Xiao WH
        • Bennett GJ
        The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries.
        Neuroscience. 2011; 176: 447-454
        • Zheng H
        • Xiao WH
        • Bennett GJ
        Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.
        Experimental Neurol. 2011; 232: 154-161
        • Zheng Q
        • Fang D
        • Liu M
        • Cai J
        • Wan Y
        • Han JS
        • Xing GG
        Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model.
        Pain. 2013; 154: 434-448
        • Zhou J
        • Liu M
        • Aneja R
        • Chandra R
        • Joshi HC
        Enhancement of paclitaxel-induced microtubule stabilization, mitotic arrest, and apoptosis by the microtubule-targeting agent EM012.
        Biochem Pharmacol. 2004; 68: 2435-2441